SWOG clinical trial number
SWOG-8302

Study of Doxorubicin, Mitomycin-C and 5-Fluorouracil in the Treatment of Metastatic Adenocarcinoma of the Prostate

Closed
Phase
Published
Abbreviated Title
Study of Doxorubicin, Mitomycin-C and 5-Fluorouracil in the Treatment of Metastatic Adenocarcinoma of the Prostate
Activated
07/26/1983
Closed
08/17/1984

Publication Information Expand/Collapse

1993

Doxorubicin, mitomycin C and 5-fluorouracil in the treatment of hormone refractory adenocarcinoma of the prostate: A Southwest Oncology Group study.

B Blumenstein;ED Crawford;JH Saiers;RL Stephens;SE Rivkin;MF Sarosdy;CA Coltman Jr;B Tranum;J Costanzi Journal of Urology 150:411-413

1985

Treatment of Stage DII adenocarcinoma of the prostate with doxorubicin, mitomycin-C and 5-fluorouracil (DMF): A Southwest Oncology Group study.

JH Saiers;BL Tranum;R Stephens;ED Crawford ASCO, #C-423